|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク,インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
JP3008226B2
(ja)
|
1991-01-16 |
2000-02-14 |
第一製薬株式会社 |
六環性化合物
|
|
US5637770A
(en)
|
1991-01-16 |
1997-06-10 |
Daiichi Pharmaceutical Co., Ltd. |
Hexa-cyclic compound
|
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
|
JP3359955B2
(ja)
|
1992-07-16 |
2002-12-24 |
第一製薬株式会社 |
抗腫瘍剤
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
JPH08337584A
(ja)
|
1995-04-10 |
1996-12-24 |
Dai Ichi Seiyaku Co Ltd |
縮合六環式アミノ化合物、これを含有する医薬及びその製法
|
|
US6504029B1
(en)
|
1995-04-10 |
2003-01-07 |
Daiichi Pharmaceutical Co., Ltd. |
Condensed-hexacyclic compounds and a process therefor
|
|
SG50747A1
(en)
|
1995-08-02 |
1998-07-20 |
Tanabe Seiyaku Co |
Comptothecin derivatives
|
|
CA2192725C
(en)
|
1995-12-28 |
2004-04-20 |
Kenji Tsujihara |
Camptothecin derivatives
|
|
JPH1095802A
(ja)
|
1995-12-28 |
1998-04-14 |
Tanabe Seiyaku Co Ltd |
カンプトテシン誘導体
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
TW527183B
(en)
|
1996-06-06 |
2003-04-11 |
Daiichi Seiyaku Co |
Drug complex
|
|
TW409058B
(en)
|
1996-06-06 |
2000-10-21 |
Daiichi Seiyaku Co |
Method for preparation of a drug complex
|
|
JPH1171280A
(ja)
|
1997-06-26 |
1999-03-16 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
JPH1192405A
(ja)
|
1997-09-19 |
1999-04-06 |
Dai Ichi Seiyaku Co Ltd |
薬物複合体
|
|
US6071719A
(en)
|
1998-03-11 |
2000-06-06 |
Smithkline Beecham Corporation |
DNA encoding ECR 673: A 7-transmembrane G-protein coupled receptor
|
|
EA003398B1
(ru)
|
1998-05-22 |
2003-04-24 |
Дайити Фармасьютикал Ко., Лтд. |
Лекарственный комплекс c полимерным носителем
|
|
HK1042438A1
(zh)
|
1998-10-30 |
2002-08-16 |
第一制药株式会社 |
Dds化合物及其测定方法
|
|
KR20020012292A
(ko)
|
1999-06-25 |
2002-02-15 |
제넨테크, 인크. |
항-ErbB 항체-메이탄시노이드 결합체를 사용한 치료방법
|
|
PL203326B1
(pl)
|
1999-06-25 |
2009-09-30 |
Genentech Inc |
Przeciwciało, kompozycja farmaceutyczna, koniugat, izolowany kwas nukleinowy, wektor, komórka gospodarza i sposób wytwarzania przeciwciała
|
|
JP2002060351A
(ja)
|
2000-03-22 |
2002-02-26 |
Dai Ichi Seiyaku Co Ltd |
水酸基を有する薬物を含むdds化合物
|
|
IL153505A0
(en)
|
2000-06-29 |
2003-07-06 |
Daiichi Seiyaku Co |
Dds compound and process for the preparation thereof
|
|
CN1556712A
(zh)
|
2000-07-13 |
2004-12-22 |
��һ��������ҩ��ʽ���� |
含dds化合物的药用组合物
|
|
US20030018989A1
(en)
|
2001-03-29 |
2003-01-23 |
Brennan Thomas J. |
Transgenic mice containing GPCR5-1 gene disruptions
|
|
EP1283053A1
(en)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
TWI313609B
(en)
|
2001-08-21 |
2009-08-21 |
Mitsubishi Tanabe Pharma Corp |
Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
|
|
US20050123536A1
(en)
|
2001-11-20 |
2005-06-09 |
Che-Leung Law |
Treatment of immunological disorders using anti-dc30 antibodies
|
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
US9745380B2
(en)
|
2002-03-01 |
2017-08-29 |
Immunomedics, Inc. |
RS7 antibodies
|
|
EP1483295B1
(en)
|
2002-03-01 |
2008-12-10 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
US20080260744A1
(en)
|
2002-09-09 |
2008-10-23 |
Omeros Corporation |
G protein coupled receptors and uses thereof
|
|
CA2498264A1
(en)
|
2002-09-09 |
2004-05-13 |
Nura, Inc. |
G protein coupled receptors and uses thereof
|
|
JP4959136B2
(ja)
|
2002-12-13 |
2012-06-20 |
イミューノメディクス、インコーポレイテッド |
細胞内で開裂可能な結合を有する免疫接合体
|
|
DK1583830T3
(da)
|
2003-01-07 |
2007-01-15 |
Symphogen As |
Fremgangsmåde til fremstilling af rekombinante polyklonale proteiner
|
|
US20040202666A1
(en)
|
2003-01-24 |
2004-10-14 |
Immunomedics, Inc. |
Anti-cancer anthracycline drug-antibody conjugates
|
|
WO2005040825A2
(en)
|
2003-10-24 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
|
|
MXPA06009701A
(es)
|
2004-02-26 |
2007-03-26 |
Inotek Pharmaceuticals Corp |
Derivados de isoquinolina y metodos de uso de los mismos.
|
|
ES2533695T3
(es)
|
2004-03-02 |
2015-04-14 |
Seattle Genetics, Inc. |
Anticuerpos cargados parcialmente y métodos para su conjugación
|
|
WO2005112919A2
(en)
|
2004-05-19 |
2005-12-01 |
Medarex, Inc. |
Self-immolative linkers and drug conjugates
|
|
CA2567520A1
(en)
|
2004-06-01 |
2005-12-15 |
Genentech, Inc. |
Maytansinoid-antibody conjugates
|
|
RS53594B1
(sr)
|
2004-07-22 |
2015-02-27 |
Genentech, Inc. |
Preparat her2 antitela
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
CA2587589A1
(en)
|
2004-11-29 |
2006-06-22 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
CN102580084B
(zh)
|
2005-01-21 |
2016-11-23 |
健泰科生物技术公司 |
Her抗体的固定剂量给药
|
|
DE102005009084A1
(de)
|
2005-02-28 |
2006-08-31 |
Ktb Tumorforschungsgesellschaft Mbh |
Proteinbindende Anthrazyklin-Peptid-Derivate und diese enthaltende Arzneimittel
|
|
DE102005009099A1
(de)
|
2005-02-28 |
2006-08-31 |
Ktb Tumorforschungsgesellschaft Mbh |
Proteinbindende Camptothecin-Peptid-Derivate und diese enthaltende Arzneimittel
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US20080131428A1
(en)
|
2006-02-24 |
2008-06-05 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US8524865B2
(en)
|
2006-05-30 |
2013-09-03 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
UA95958C2
(en)
|
2006-05-30 |
2011-09-26 |
Дженентек, Инк. |
Antibody that binds to cd22, immunoconjugates and uses therefor
|
|
ITMI20061473A1
(it)
|
2006-07-26 |
2008-01-27 |
Indena Spa |
Derivati della camptotecina ad attivita antitumorale
|
|
EP2109607A1
(en)
|
2006-12-21 |
2009-10-21 |
Schering Corporation |
Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
|
|
SI2716301T1
(sl)
|
2007-02-16 |
2017-07-31 |
Merrimack Pharmaceuticals, Inc. |
Protitelesa proti ErbB3 in uporaba le-teh
|
|
EP2121008A4
(en)
|
2007-03-22 |
2010-03-31 |
Sloan Kettering Inst Cancer |
USE OF MONOCLONAL ANTIBODY 8H9
|
|
US8354102B2
(en)
|
2007-05-15 |
2013-01-15 |
Hoffmann-La Roche Inc. |
Antibodies directed to mGluR7
|
|
RU2475499C2
(ru)
|
2007-10-11 |
2013-02-20 |
Дайити Санкио Компани, Лимитед |
Антитело, направленное на белок siglec-15, связанный с остеокластами
|
|
CN104524592B
(zh)
|
2008-04-30 |
2018-06-05 |
伊缪诺金公司 |
交联剂和它们的用途
|
|
EP2277044B1
(en)
|
2008-05-13 |
2015-06-17 |
Genentech, Inc. |
Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
|
|
JP5677972B2
(ja)
|
2008-11-18 |
2015-02-25 |
メリマック ファーマシューティカルズ インコーポレーティッド |
ヒト血清アルブミンリンカーおよびそのコンジュゲート
|
|
EP3903829B1
(en)
|
2009-02-13 |
2023-05-03 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
CN106317224B
(zh)
|
2009-04-09 |
2020-05-12 |
第一三共株式会社 |
抗-Siglec-15抗体
|
|
KR20120104158A
(ko)
|
2009-07-22 |
2012-09-20 |
엔즌 파마슈티칼스, 인코포레이티드 |
7-에틸-10-히드록시캠토테신의 다분지형 중합 컨쥬게이트와 her2 수용체 길항제를 병용하여 her2 양성 암을 치료하는 방법
|
|
WO2011021397A1
(ja)
|
2009-08-20 |
2011-02-24 |
国立大学法人千葉大学 |
コルヒチン誘導体
|
|
CA2775350A1
(en)
|
2009-09-24 |
2011-03-31 |
Seattle Genetics, Inc. |
Dr5 ligand drug conjugates
|
|
MX341136B
(es)
|
2009-10-20 |
2016-08-09 |
Abbvie Inc |
Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a.
|
|
KR101806323B1
(ko)
|
2009-11-13 |
2017-12-07 |
다이이치 산쿄 유럽 게엠베하 |
Her-3 관련 질병을 치료하거나 예방하기 위한 물질 및 방법
|
|
ES2978177T3
(es)
|
2009-12-02 |
2024-09-06 |
Immunomedics Inc |
Combinación de radio inmunoterapia y conjugados anticuerpo-fármaco para mejorar la terapia contra el cáncer
|
|
WO2011143209A1
(en)
|
2010-05-13 |
2011-11-17 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting nuclear hormone receptor activity
|
|
SG185583A1
(en)
|
2010-05-17 |
2012-12-28 |
Livtech Inc |
Anti-human trop-2 antibody having antitumor activity in vivo
|
|
CN103037903A
(zh)
|
2010-05-18 |
2013-04-10 |
天蓝制药公司 |
用于治疗自身免疫性疾病或其它疾病的组合物和方法
|
|
WO2011155579A1
(ja)
|
2010-06-10 |
2011-12-15 |
北海道公立大学法人札幌医科大学 |
抗Trop-2抗体
|
|
PE20130643A1
(es)
|
2010-07-12 |
2013-06-07 |
Covx Technologies Ireland Ltd |
Conjugados de anticuerpos multifuncionales
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
US20120156130A1
(en)
|
2010-08-06 |
2012-06-21 |
Thore Hettmann |
Use of her3 binding agents in prostate treatment
|
|
EP2638066A4
(en)
|
2010-11-09 |
2015-06-03 |
Medimmune Llc |
ANTIBODY EQUIPMENT FOR HOMOGENEOUS CONJUGATION
|
|
EP2640727B1
(en)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
CN104053672A
(zh)
|
2011-11-11 |
2014-09-17 |
瑞纳神经科学公司 |
Trop-2特异性抗体及其用途
|
|
US9427464B2
(en)
|
2011-11-22 |
2016-08-30 |
Chiome Bioscience Inc. |
Anti-human TROP-2 antibody having an antitumor activity in vivo
|
|
MX2014007121A
(es)
|
2011-12-14 |
2014-09-04 |
Seattle Genetics Inc |
Nuevos conjugados de principio activo-ligante (adc) y su uso.
|
|
US20130280282A1
(en)
|
2012-04-24 |
2013-10-24 |
Daiichi Sankyo Co., Ltd. |
Dr5 ligand drug conjugates
|
|
CA2876706A1
(en)
|
2012-06-14 |
2013-12-19 |
Ambrx, Inc. |
Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
|
|
KR102237639B1
(ko)
|
2012-10-11 |
2021-04-07 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트
|
|
ES2782248T3
(es)
|
2012-10-19 |
2020-09-11 |
Daiichi Sankyo Co Ltd |
Conjugado de anticuerpo y fármaco producido por la unión a través de un enlazador que tiene estructura hidrófila
|
|
MX367748B
(es)
|
2012-12-21 |
2019-09-04 |
Glenmark Pharmaceuticals Sa |
Formulación de anticuerpo anti her2.
|
|
US9814784B2
(en)
|
2013-01-03 |
2017-11-14 |
Celltrion, Inc. |
Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same
|
|
IL320281A
(en)
|
2013-12-25 |
2025-06-01 |
Daiichi Sankyo Co Ltd |
Anti-trop2 antibodies and methods for producing same
|
|
PH12020552271A1
(en)
|
2014-01-31 |
2022-05-02 |
Daiichi Sankyo Co Ltd |
Anti-her2 antibody-drug conjugate
|
|
ES2939760T3
(es)
|
2014-03-15 |
2023-04-26 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico para antígenos
|
|
JP2017114763A
(ja)
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗cd98抗体−薬物コンジュゲート
|
|
EP3130608B1
(en)
|
2014-04-10 |
2019-09-04 |
Daiichi Sankyo Co., Ltd. |
(anti-her2 antibody)-drug conjugate
|
|
DK3129063T3
(da)
|
2014-04-10 |
2021-04-06 |
Daiichi Sankyo Co Ltd |
Anti-her3-antistof-lægemiddelkonjugat
|
|
US9982045B2
(en)
|
2014-08-12 |
2018-05-29 |
Novartis Ag |
Anti-CDH6 antibody drug conjugates
|
|
CN111529717A
(zh)
|
2015-02-17 |
2020-08-14 |
上海美雅珂生物技术有限责任公司 |
抗体药物偶联物
|
|
US11173213B2
(en)
|
2015-06-29 |
2021-11-16 |
Daiichi Sankyo Company, Limited |
Method for selectively manufacturing antibody-drug conjugate
|
|
CN108700598A
(zh)
*
|
2016-03-25 |
2018-10-23 |
豪夫迈·罗氏有限公司 |
多路总抗体和抗体缀合的药物量化测定法
|
|
CA3036941C
(en)
|
2016-10-07 |
2023-02-21 |
Daiichi Sankyo Company, Limited |
Therapy for drug-resistant cancer by administration of anti-her2 antibody/drug conjugate
|
|
EP3572428A4
(en)
|
2017-01-17 |
2020-12-30 |
Daiichi Sankyo Company, Limited |
ANTI-BODY ANTI-GPR20 AND ANTI-BODY-DRUG CONJUGATE ANTI-GPR20
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
TW202530271A
(zh)
|
2017-05-15 |
2025-08-01 |
日商第一三共股份有限公司 |
抗體-藥物結合物及其用途
|